Microbot Medical Q4 EPS $(0.26) Misses $(0.25) Estimate
Portfolio Pulse from Happy Mohamed
Microbot Medical (MBOT) reported a Q4 EPS loss of $(0.26), missing the consensus estimate of $(0.25) by 4%. This represents a 31.58% improvement over the $(0.38) per share loss from the same period last year.
March 28, 2024 | 3:47 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Microbot Medical reported a Q4 EPS loss of $(0.26), missing estimates by 4% but improved 31.58% YOY.
Missing the EPS estimate could negatively impact investor sentiment in the short term, despite the year-over-year improvement in losses. The miss, although slight, may lead to a decrease in stock price as it indicates the company is not performing as well as expected.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100